Company
Kyron.bio
Pioneering tomorrow's therapeutics through glycan engineering.
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Headquarters
- Paris, France
Claim, correct or request removal
Record updated 28 September 2026
About
kyron.bio unlocks superior protein therapeutics by harnessing the power of glycan modifications.
Funding snapshot
- Latest round
- Seed2025
Funding rounds
- Seed
- 2025
Loading relationship preview